Literature DB >> 2470746

Interactions between human extracellular superoxide dismutase C and sulfated polysaccharides.

T Adachi1, S L Marklund.   

Abstract

The high heparin affinity subtype C of the secretory enzyme extracellular superoxide dismutase (EC-SOD) exists in the body mainly complexed with extracellular sulfated glycosaminoglycans (SGAGs). Addition of sulfated polysaccharides to EC-SOD C resulted in a prompt partial inhibition of the enzymic activity, in most cases amounting to 10-17%, but with the large dextran sulfate 500,000 amounting to 35%. Complex formation between heparin and EC-SOD C could also be observed as increases in apparent molecular weight of the enzyme. The findings suggest that the binding sites for SGAGs on EC-SOD C are localized far from the active site and that EC-SOD in vivo associated with SGAGs should retain the major part of its enzymic activity. Studies with amino acid-specific reagents suggested that both lysine and arginine residues are involved in the binding of SGAGs. In particular, modification of only a few lysine residues/subunit resulted in loss of high SGAG affinity, whereas arginine modification resulted in loss of not only SGAG affinity but also enzymic activity. We propose that this is due to modification of Arg-186, which is homologous to the highly conserved arginine in the entrance to the active site of the copperzinc-SODs.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2470746

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  19 in total

1.  Expression of extracellular superoxide dismutase by human cell lines.

Authors:  S L Marklund
Journal:  Biochem J       Date:  1990-02-15       Impact factor: 3.857

Review 2.  Heparan sulfate-protein binding specificity.

Authors:  M A Nugent; J Zaia; J L Spencer
Journal:  Biochemistry (Mosc)       Date:  2013-07       Impact factor: 2.487

3.  Extracellular superoxide dismutase in cultured astrocytes: decrease in cell-surface activity and increase in medium activity by lipopolysaccharide-stimulation.

Authors:  Ichiro Iitsuka; Akiko Motoyoshi-Yamashiro; Mitsuaki Moriyama; Yukiko Kannan-Hayashi; Yuka Fujimoto; Katsura Takano; Koji Murakami; Yukio Yoneda; Yoichi Nakamura
Journal:  Neurochem Res       Date:  2012-06-28       Impact factor: 3.996

Review 4.  Extracellular superoxide dismutase and its role in cancer.

Authors:  Brandon Griess; Eric Tom; Frederick Domann; Melissa Teoh-Fitzgerald
Journal:  Free Radic Biol Med       Date:  2017-08-24       Impact factor: 7.376

Review 5.  Small proteoglycans.

Authors:  H Kresse; H Hausser; E Schönherr
Journal:  Experientia       Date:  1993-05-15

6.  Non-enzymic glycation of human extracellular superoxide dismutase.

Authors:  T Adachi; H Ohta; K Hirano; K Hayashi; S L Marklund
Journal:  Biochem J       Date:  1991-10-01       Impact factor: 3.857

7.  Proteolytic modification of the heparin-binding affinity of extracellular superoxide dismutase.

Authors:  K Karlsson; A Edlund; J Sandström; S L Marklund
Journal:  Biochem J       Date:  1993-03-01       Impact factor: 3.857

8.  Substitution of glycine for arginine-213 in extracellular-superoxide dismutase impairs affinity for heparin and endothelial cell surface.

Authors:  T Adachi; H Yamada; Y Yamada; N Morihara; N Yamazaki; T Murakami; A Futenma; K Kato; K Hirano
Journal:  Biochem J       Date:  1996-01-01       Impact factor: 3.857

9.  Heparin-affinity patterns and composition of extracellular superoxide dismutase in human plasma and tissues.

Authors:  J Sandström; K Karlsson; T Edlund; S L Marklund
Journal:  Biochem J       Date:  1993-09-15       Impact factor: 3.857

10.  The high concentration of Arg213-->Gly extracellular superoxide dismutase (EC-SOD) in plasma is caused by a reduction of both heparin and collagen affinities.

Authors:  Steen V Petersen; Dorte Aa Olsen; John M Kenney; Tim D Oury; Zuzana Valnickova; Ida B Thøgersen; James D Crapo; Jan J Enghild
Journal:  Biochem J       Date:  2005-01-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.